NYSE$ZBH
Zimmer Biomet Holdings Inc · Q1 2020 earnings
Q1 2020 earnings · · Investor relations
Briefing
Zimmer Biomet's financial performance was impacted by the COVID-19 pandemic, resulting in decreased net sales and a net loss for the first quarter.
Zimmer Biomet reported a 9.7% decrease in net sales to $1.784 billion for the first quarter of 2020. The company experienced a net loss of $509 million, which includes goodwill impairment, but net earnings on an adjusted basis were $354 million. The COVID-19 pandemic significantly impacted elective procedure volumes, negatively affecting the company's performance.
- First quarter net sales decreased by 9.7% to $1.784 billion, or 8.9% on a constant currency basis.
- The company reported a diluted loss per share of $2.46, while adjusted diluted earnings per share were $1.70.
- COVID-19 pandemic significantly impacted elective procedure volumes, negatively affecting performance.
- The company refinanced $1.5 billion in debt, renegotiated its $1.5 billion revolver, and secured an additional $1.0 billion credit facility.
Headline financials
Revenue & EPS history
Zimmer Biomet · Revenue · Quarterly
$1.78B
Revenue by segment
Zimmer Biomet · $1.4B total across 3 segments · Q1 2020
- Knees Net Sales$630M-9.3%45.1%
- Hips Net Sales$433M-10.5%31.0%
- S.E.T. Net Sales$334M-6.5%23.9%
Forward guidance
Zimmer Biomet expects the decline in elective procedure volumes observed in the final weeks of the first quarter to continue to have a significant negative impact in the second quarter of 2020. Given the uncertainty around the scope and duration of COVID-19 and its ongoing impact on the deferral of elective procedures, the Company is currently unable to quantify the expected impact on its results of operations, financial condition and cash flows, which could be material, for 2020 and is therefore not providing full-year financial guidance.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2020
-0.4%
Avg return
Earnings day
-1.7%
Avg return
5 days after
-2.3%
Avg return
30 days after
42%
30 / 72 earnings
Positive
+11.9%
Q3 2020
Best reaction
-15.3%
Q3 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.1% | -10.5% | -11.5% | |
| Q4 2025 | +1.9% | +7.5% | +3.2% | |
| Q3 2025 | -15.2% | -14.0% | -8.6% | |
| Q1 2025 | -11.6% | -7.0% | -10.7% | |
| Q4 2024 | -5.1% | -8.6% | -0.2% | |
| Q3 2024 | +2.9% | +4.4% | +7.9% | |
| Q2 2024 | -0.8% | -2.3% | -4.3% | |
| Q1 2024 | +1.8% | +1.6% | -3.7% | |
| Q4 2023 | -3.7% | -3.4% | -0.6% | |
| Q3 2023 | -4.1% | -3.5% | +7.3% | |
| Q2 2023 | -7.1% | -8.6% | -13.8% | |
| Q1 2023 | +0.6% | -0.7% | -8.3% | |
| Q4 2022 | +0.9% | +2.6% | -0.9% | |
| Q3 2022 | -5.7% | -3.9% | +10.0% | |
| Q2 2022 | +5.3% | +3.2% | -2.7% | |
| Q1 2022 | +4.7% | -0.3% | +1.2% | |
| Q4 2021 | -2.4% | -5.4% | -1.4% | |
| Q3 2021 | -4.8% | -9.7% | -18.5% | |
| Q2 2021 | -9.1% | -8.6% | -8.5% | |
| Q1 2021 | -2.5% | -3.1% | -10.1% | |
| Q4 2020 | -0.6% | -0.2% | -1.4% | |
| Q3 2020 | +11.9% | +7.2% | +7.0% | |
| Q2 2020 | -1.5% | +2.7% | +3.5% | |
| Q1 2020 | -6.8% | -7.8% | +10.2% | |
| Q4 2019 | +6.2% | +5.3% | -13.0% | |
| Q3 2019 | +4.9% | +5.5% | +8.1% | |
| Q2 2019 | +8.6% | +9.1% | +7.9% | |
| Q1 2019 | -3.1% | -2.8% | -8.2% | |
| Q4 2018 | +7.8% | +7.9% | +14.5% | |
| Q3 2018 | -5.6% | -7.0% | -7.7% | |
| Q2 2018 | +8.0% | +7.1% | +7.1% | |
| Q1 2018 | +5.7% | +5.8% | +0.4% | |
| Q4 2017 | -0.2% | -1.3% | -10.9% | |
| Q3 2017 | -7.7% | -10.1% | -5.8% | |
| Q2 2017 | -3.8% | -6.5% | -12.1% | |
| Q1 2017 | -4.5% | -3.7% | -4.9% | |
| Q4 2016 | +2.7% | +2.4% | +2.3% | |
| Q3 2016 | -15.3% | -15.9% | -16.9% | |
| Q2 2016 | +6.9% | +6.4% | +5.6% | |
| Q1 2016 | -0.1% | — | — | |
| Q4 2015 | -2.3% | — | — | |
| Q3 2015 | +6.8% | — | — | |
| Q2 2015 | -2.7% | — | — | |
| Q1 2015 | -4.3% | — | — | |
| Q4 2014 | -2.1% | — | — | |
| Q3 2014 | +5.1% | — | — | |
| Q2 2014 | -2.3% | — | — | |
| Q1 2014 | +9.9% | — | — | |
| Q4 2013 | +0.8% | — | — | |
| Q3 2013 | -3.3% | — | — | |
| Q2 2013 | +0.5% | — | — | |
| Q1 2013 | +0.6% | — | — | |
| Q4 2012 | -1.3% | — | — | |
| Q3 2012 | +2.0% | — | — | |
| Q2 2012 | -3.5% | — | — | |
| Q1 2012 | -0.6% | — | — | |
| Q4 2011 | -1.3% | — | — | |
| Q3 2011 | +3.7% | — | — | |
| Q2 2011 | -5.6% | — | — | |
| Q1 2011 | +0.5% | — | — | |
| Q4 2010 | +2.2% | — | — | |
| Q3 2010 | +3.6% | — | — | |
| Q2 2010 | -1.5% | — | — | |
| Q1 2009 | -0.8% | — | — | |
| Q1 2010 | +1.6% | — | — | |
| Q4 2009 | -0.2% | — | — | |
| Q3 2009 | +4.0% | — | — | |
| Q3 2008 | +4.0% | — | — | |
| Q4 2007 | -1.0% | — | — | |
| Q2 2008 | -1.0% | — | — | |
| Q2 2009 | -1.0% | — | — | |
| Q4 2008 | -1.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro